GH Peptide Stack GH Peptide Stack STACK IMAGE
BATCH COA SUPPLIED HPLC VERIFIED RESEARCH USE ONLY
— STACK · 2 COMPOUNDS

GH Peptide Stack CJC-1295 wo DAC + Tesamorelin

For in vitro research use only. GH Peptide Stack is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

Research bundle combining two growth hormone-releasing hormone analogues with complementary properties. CJC-1295 without DAC produces a shorter, more physiologically pulsatile GH release pattern; Tesamorelin offers a longer active window with an established clinical research dataset.

Research overview

Research bundle combining two growth hormone-releasing hormone analogues with complementary properties. CJC-1295 without DAC produces a shorter, more physiologically pulsatile GH release pattern; Tesamorelin offers a longer active window with an established clinical research dataset. Together they allow comparison of different GHRH analogue profiles in GH secretion research. Two individual lyophilised vials. For in vitro research use only.

Compounds in this stack

CJC-1295 wo DAC

Growth Hormone Releasing Factor Analogue (no DAC)

A synthetic analogue of the natural signal the brain uses to trigger growth hormone release. The absence of a Drug Affinity Complex (DAC) means it produces a shorter, sharper pulse of GH release — more closely mimicking the natural physiological pattern than longer-acting variants.

CAS 863288-34-0 99.1% HPLC View CJC-1295 wo DAC →

Tesamorelin

Growth Hormone Releasing Factor Analogue

A synthetic analogue of the full-length growth hormone-releasing hormone (GHRH), with structural modifications that slow its breakdown and extend its active window. Investigated in preclinical and clinical research for its effects on GH and IGF-1 production, and studied in specific patient groups for its influence on visceral fat distribution.

CAS 218949-48-9 98.6% HPLC View Tesamorelin →

For in vitro research use only. This stack is supplied solely as research reagents for qualified professionals conducting in vitro or animal-model studies. No compound in this stack is a medicinal product. None has been evaluated by the MHRA or FDA. None is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.